does medicaid cover glp-1 covers weight-loss drugs in just 13 states Who Gets the Shot? GLP-1

Cagrilintide monotherapy weight loss In the phase 2 trial over 26 weeks, cagrilintide weight loss ranged from 6.0% to 10.8% of body weight depending on dose

Who This Program May Be a Fit For TeleHealth Med May Align Well With People Who: Meet established medical criteria for GLP-1 treatment

And How Much Compounded GLP-1 Really Costs in 2026 breaks down what you should actually pay

Glucagon-like peptide-1 receptor agonist Exendin-4 improves neurological outcomes by attenuating TBI- induced inflammatory responses and MAPK activation in rats

Multiple banks, such as BMO Capital Markets, 8 Morningstar 9 and Goldman Sachs 10 expect the market to grow to or beyond $100bn by 2030, with some, such as JP Morgan, 11 predicting as high as $140bn by 2032